Qube Research & Technologies (QRT)’s Maravai LifeSciences MRVI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.67M	Buy	+748,447	New	+$3.23M	﹤0.01%	1665
2024 Q1	–	Sell	-805,954	Closed	-$5.28M	–	4728
2023 Q4	$5.28M	Buy	+805,954	New	+$5.21M	0.01%	1006
2023 Q3	–	Sell	-89,934	Closed	-$1.12M	–	4249
2023 Q2	$1.12M	Sell	89,934 -891,223	-91%	-$12M	﹤0.01%	1263
2023 Q1	$13.7M	Sell	981,157 -253,928	-21%	-$3.65M	0.06%	360
2022 Q4	$17.7M	Buy	1,235,085 +1,182,684	+2,257%	+$18.6M	0.09%	313
2022 Q3	$1.34M	Buy	52,401 +30,660	+141%	+$769K	0.01%	1087
2022 Q2	$618K	Sell	21,741 -10,815	-33%	-$343K	﹤0.01%	1320
2022 Q1	$1.15M	Sell	32,556 -79,027	-71%	-$2.65M	0.01%	1103
2021 Q4	$4.67M	Buy	111,583 +67,774	+155%	+$2.75M	0.04%	578
2021 Q3	$2.15M	Buy	43,809 +460	+1%	+$22.4K	0.03%	654
2021 Q2	$1.81M	Sell	43,349 -3,487	-7%	-$135K	0.02%	742
2021 Q1	$1.67M	Buy	46,836 +37,085	+380%	+$1.23M	0.03%	675
2020 Q4	$274K	Buy	+9,751	New	+$272K	﹤0.01%	1392

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MRVI Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Maravai LifeSciences (MRVI) in Q2 2026: 748,447 shares worth $4.67M. The stake represents ﹤0.01% of the portfolio and ranks #1665 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in MRVI as recently as Q4 2023.

Qube Research & Technologies (QRT) first reported a position in MRVI in Q4 2020 and has held it in 13 quarters since. The position peaked at $17.7M in Q4 2022. 177 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Qube Research & Technologies (QRT) held 748,447 shares of Maravai LifeSciences worth $4.67M as of Q2 2026.
Maravai LifeSciences was a new Qube Research & Technologies (QRT) position in Q2 2026.
Maravai LifeSciences made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1665 holding.
Qube Research & Technologies (QRT) first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 13 quarters since.
Qube Research & Technologies (QRT)'s Maravai LifeSciences position peaked at $17.7M in Q4 2022.
177 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.